Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with ...

Govindachamy, who has only one arm, escaped from Kannur Central Jail in the early hours of July 24, 2025. He was later captured from a well at Thalappu, about three kilometres away ...

At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting "armored" CAR T-cell therapy that is designed to ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

A Texas father and son are both back home and getting to spend Christmas together after they were hospitalized recently.

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

At the recent American Society of Hematology annual meeting, real-world analyses examined how polatuzumab vedotin (Polivy) ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

Researchers at RMIT University in Melbourne have developed minuscule 'nanodots' that show promise for future targeted cancer ...